ERBB2 and gastric cancer: Concerning gastric cancer, case series studies have been performed on this topic, 51 gastric NECs (15 pure and 36 associated with adenocarcinoma and/or dysplasia) were analyzed, and HER2 amplification was reported in 3 NECs (6%) and 7 (19%) mixed tumors.